Dino Mustafić

October 20, 2015 Off

$22.9 million in Planning Grants for Certified Community Behavioral Health Clinics

The Substance Abuse and Mental Health Services Administration (SAMHSA), in conjunction with the Centers for Medicare & Medicaid Services (CMS) and the Assistant Secretary of Planning and Evaluation (ASPE), today awarded a total of $22.9 million to support states throughout the nation in their efforts to improve behavioral health of their citizens by providing community-based mental and substance use disorder treatment.

October 20, 2015 Off

HHS: New members of Advisory Council on Alzheimer’s Research, Care, and Services

By Dino Mustafić

Secretary of U.S. Department of Health & Human Services (HSS) Sylvia M. Burwell on Tuesday announced six new members to serve on the Advisory Council on Alzheimer’s Research, Care, and Services.

October 19, 2015 Off

Allergen wraps up AqueSys buy (Including $300M up-front payment)

By Dino Mustafić

Allergan plc has completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that…

October 19, 2015 Off

Shire disappointed, wating lifitegrast, OPUS-3 study, data

By Dino Mustafić

“We were disappointed, but will soon have data from the Phase 3 study, OPUS 3,” said Flemming Ornskov, M.D., CEO, Shire.

October 16, 2015 Off

FDA: Blood thinners can prevent strokes

By Dino Mustafić

Blood thinner (anticoagulant) can reduce the risk of a stroke by 50% to 60% for people who have atrial fibrillation.

October 16, 2015 Off

FDA approved Praxbind for patients taking Pradaxa

By Dino Mustafić

The U.S. Food and Drug Administration on Friday granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.

October 16, 2015 Off

Onabotulinumtoxin A treatment decrease urinary incontinence in women

By Dino Mustafić

“These findings may help inform specialists treating patients with overactive bladder, that BOTOX is an effective and safe treatment option for patients not getting the relief from an anticholinergic.”

October 16, 2015 Off

The Wolfson Institute and Premaitha Health: World first in-house antenatal reflex DNA screening

By Dino Mustafić

The Wolfson Institute of Preventive Medicine with the assistance of Premaitha Health plc , is launching an in-house antenatal reflex DNA screening service on 19 October 2015.

October 16, 2015 Off

USA:Recall of lot # 45810 of Acetaminophen tablets

By Dino Mustafić

Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot # 45810 of Acetaminophen tablets, 500mg, uncoated compressed tablets to the consumer level.

October 15, 2015 Off

BMS – Five Prime Agreement

By Dino Mustafić

Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc. have announced that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Five Prime’s colony stimulating factor 1 receptor (CSF1R) antibody program, including FPA008 which is in Phase 1 development for immunology and oncology indications.